Revolution Medicines Inc (NASDAQ: RVMD) started the day on Wednesday, with a price increase of 10.64% at $36.50, before settling in for the price of $32.99 at the close. Taking a more long-term approach, RVMD posted a 52-week range of $15.44-$35.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 11.11% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -36.05%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 17.78%. This publicly-traded company’s shares outstanding now amounts to $164.67 million, simultaneously with a float of $136.49 million. The organization now has a market capitalization sitting at $6.01 billion. At the time of writing, stock’s 50-day Moving Average stood at $30.68, while the 200-day Moving Average is $27.89.
Revolution Medicines Inc (RVMD) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Revolution Medicines Inc’s current insider ownership accounts for 17.13%, in contrast to 79.18% institutional ownership. According to the most recent insider trade that took place on Mar 27 ’24, this organization’s General Counsel sold 1,500 shares at the rate of 30.99, making the entire transaction reach 46,481 in total value, affecting insider ownership by 54,374. Preceding that transaction, on Mar 18 ’24, Company’s insider sold 5,788 for 31.58, making the whole transaction’s value amount to 182,804. This particular insider is now the holder of 460,379 in total.
Revolution Medicines Inc (RVMD) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2023, the organization reported -$1.14 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.88) by -$0.26. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.77 per share during the current fiscal year.
Revolution Medicines Inc’s EPS increase for this current 12-month fiscal period is 17.78% and is forecasted to reach -3.41 in the upcoming year.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Let’s observe the current performance indicators for Revolution Medicines Inc (RVMD). It’s Quick Ratio in the last reported quarter now stands at 13.06. The Stock has managed to achieve an average true range (ATR) of 1.64. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 519.10.
In the same vein, RVMD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.77, a figure that is expected to reach -0.75 in the next quarter, and analysts are predicting that it will be -3.41 at the market close of one year from today.
Technical Analysis of Revolution Medicines Inc (RVMD)
If we take a close look at the recent performances of Revolution Medicines Inc (NASDAQ: RVMD), its last 5-days Average volume was 1.81 million that shows progress from its year to date volume of 1.38 million. During the previous 9 days, stock’s Stochastic %D was recorded 85.02% While, its Average True Range was 1.78.
Raw Stochastic average of Revolution Medicines Inc (RVMD) in the period of the previous 100 days is set at 94.11%, which indicates a major rise in contrast to 87.42% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 62.45% that was higher than 40.32% volatility it exhibited in the past 100-days period.
